Image-guided adaptive brachytherapy in the treatment of patients with cervix cancer;Curiethérapie intégrant l'imagerie dans la prise en charge des patientes atteintes d'un cancer du col utérin

Cancer/Radiotherapie

Volumn 17, Issue 2, 2013, Pages 98-105

  Haie Meder, C ^a   Thomas, L ^b   Barillot, I ^c   Pommier, P ^d   Nickers, P ^e  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT BERGONIÉ   (France)

^c CHU BRETONNEAU   (France)

^d CENTRE LÉON BÉRARD   (France)

^e CENTRE OSCAR LAMBRET   (France)

Author keywords

Cervix cancer; Image guided brachytherapy; Optimization; Three dimensional dosimetry

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; HUMAN; IMAGE GUIDED RADIOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANS AT RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SHORT SURVEY; UTERINE CERVIX CANCER;

BRACHYTHERAPY; EUROPE; FEMALE; FERTILITY PRESERVATION; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MULTICENTER STUDIES AS TOPIC; ORGANS AT RISK; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RECTAL DISEASES; REGISTRIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN; URINATION DISORDERS; UTERINE CERVICAL NEOPLASMS;

EID: 84878019475     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2013.02.002     Document Type: Short Survey

References (31)

1. Le cancer du col de l'utérus en France : état des lieux 2010. Boulogne-Billancourt: INCa; 2010. p. 5-6.
2. Haie-Meder C., Morice P., Castiglione M. Cervical cancer: ESMO recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20:27-28.
3. Georg D., Kirisits C., Hillbrand M., Dimopoulos J., Pötter R. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008, 71:1272-1278.
4. FIGO Committee on gynecologic oncology Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 2009, 105:103-104.
5. Shenfield CB, Dimopolous JCA, De Andrade Carvalho H, Fidarova EF, Pötter R. A template for clinical drawings in cancer of the cervix. In: EMBRACE (An international study on MRI-guided brachytherapy in locally advanced cervical cancer). Vienne: The Medical University of Vienna. Disponible en ligne à l'adresse : (accès le 12/2/2013). http://www.embracestudy.dk/.
6. Hricak H., Gatsoinis C., Coakley F.V., Snyder B., Reinhold C., Schwartz L.H., et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007, 245:491-498.
7. Haie-Meder C., Mazeron R., Magné N. Clinical evidence on PET-CT for radiation planning in cervix and endometrial cancers. Radiother Oncol 2010, 96:351-355.
8. Mahantshetty U., Khanna N., Swamidas J., Engineer R., Thakur M.H., Merchant N.H., et al. Trans-abdominal ultrasound and magnetic resonance imaging correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix. Radiother Oncol 2012, 102:130-134.
9. Lim K., Small W., Portelance L., Creutzberg C., Jürgenliemk-Schulz I.M., Mundt A., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys 2011, 79:348-355.
10. Small W., Mell L.K., Anderson P., Creutzberg C., De Los Santos J., Gaffney D., et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:428-434.
11. Georg P., Potter R., Georg D., Lang S., Dimopoulos J.C., Sturdza A.E., et al. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys 2012, 82:653-657.
12. Viswanathan A., Dimopoulos J., Kirisits C., Berger D., Pötter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007, 68:491-498.
13. Wachter-Gestner N., Wachter S., ReinstadlerE.Fellner C., Knocke T.H., Wambersie A., et al. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol 2003, 68:51-59.
14. Haie-Meder C., Pötter R., van Limbergen E., Barillot I., De Brabandere M., Dimopoulos J., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
15. Dimopoulos J., Petrow P., Tanderup K., Petric P., Berger D., Kirisits C., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012, 103:113-122.
16. Magné N., Chargari C., San Filippo N., Messai T., Gerbaulet A., Haie-Meder C. Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignancies. Brachytherapy 2010, 9:274-277.
17. Fletcher G.H. Uterine cervix. Textbook of radiotherapy 1980, Lea and Fibiger, Philadelphia. 2nd ed.
18. Björkholm E. The development of brachytherapy and complementary external irradiation in the treatment of cervical carcinoma Radiumhemmet, Stockholm 1910-1996. Integration of external beam therapy and brachytherapy in the treatment of cervix cancer: clinical, physical and biological aspects 1997, 71-76. ESTRO, Brussels. G. Kovacs (Ed.).
19. Kirisits C., Lang S., Dimopoulos J., Georg P., Lang S., Berger D., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006, 65:624-630.
20. Jürgenliemk-Schulz I.M., Tersteeg R.J., Roesink J.M., Bijmolt S., Nomden C.N., Moerland M.A., et al. MRI-guided treatment planning optimization in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Radiother Oncol 2009, 93:322-330.
21. Charra-Brunaud C., Harter V., Delannes M., Haie-Meder C., Quetin P., Kerr C., et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 2012, 103:305-313.
22. Pötter R., Georg P., Dimopoulos J., Grimm M., Berger D., Nesvacil N., et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011, 100:116-123.
23. Tanderup K., Lindegaard J.C., Kirisits C., Nkiwane K.S., Fidarova E., Haie-Meder C., et al. EMBRACE update. Radiother Oncol 2011, 99:S22.
24. De Brabandere M., Mousa A.G., Nulens A., Swinnen A., Van Limbergen E. Potential of dose optimization in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008, 88:217-226.
25. Lindegaard J.C., Tanderup K., Nielsen S.K., Haack S., Gelineck J. MRI-guided optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:756-764.
26. Chargari C., Magné N., Dumas I., Messai T., Vicenzi L., Gillion N., et al. Physics contribution and clinical outcome with 3D MRI-based pulsed dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 2009, 74:133-139.
27. Trotti A., Colevas A.D., Setser A., Rusch V., Jaques D., Budach V., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-181.
28. Levitchi M., Charra-Brunaud C., Quetin P., Haie-Meder C., Kerr C., Castelain B., et al. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy. Radiother Oncol 2012, 103:314-321.
29. de Leeuw A.A.C., van de Kamer J.B., Moerland M.A., Philippens M.E., Jürgenliemk-Schulz I.M. The effect of alternative biological modelling parameters (α/β and half time of repair T1/2) on reported EQD2 values in the treatment of advanced cervical cancer. Radiother Oncol 2011, 101:337-342.
30. Barillot I., Horiot J.C., Maingon P., Bone-Lepinoy M.C., Vaillant D., Feutray S. Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. Radiother Oncol 1994, 30:231-238.
31. Fellner C., Potter R., Knocke T.H., Wambersie A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001, 58:53-62.